Priority New Crown Patient UK Limited Supply Redsyway

The British Ministry of Health said Saturday that the government has begun a limited supply of the antiviral drug Redsyvir, which is expected to last until the end of October.
ministry spokesman told Reuters in an email that the health department was aware of the rise in redsiwe use across the country, in line with the rise in the number of new crown hospital admissions.
the spokesman said that while there was "still sufficient supply" in the UK, the Department of Health had asked the NHS to "temporarily give priority to the supply" of new crown patients rather than other patients. In addition, drugmaker Gilead Technologies Inc. will increase its supply of Redsyvir by the end of October.
some evidence suggests that Redsyvir can shorten the time it takes for patients with new crowns to recover and be discharged from hospital, but there is no significant evidence that the drug can reduce neo crown mortality, Reuters reported.
Department of Health also said on the 6th, although redsiway supply will increase by the end of the month, then still depends on the number of inpatients to make the next decision.
as of the evening of May 5, there were 515,571 new crown cases confirmed in the UK, with 12,594 new cases added in the past 24 hours, while there were 2,428 hospitalizations and 422 new cases in the past 24 hours.